Efficacy and tolerance of frontline bevacizumab-based chemotherapy for advanced non-small cell lung cancer patients: a multicenter, phase IV study of the Hellenic Oncology Research Group (HORG). Επικοινωνία Submitted by Δημήτρης Σπάχος on Τρί, 10/02/2018 - 12:47
